Etizolam in Timor-Leste: not individually verified
We have not confirmed that Etizolam specifically is scheduled in Timor-Leste, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.
- What is on record
- Not confirmed. Etizolam is not named in Table IV or in any other table of Lei 2/2017's Anexo II, as at 25 January 2017, the date the law was published. Table IV is not limited to conventional 1,4-benzodiazepines: item 8, "Brotizolam - 2-bromo-4-(0-clorofenil)-9-metil-6H-tieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepina", and item 18, "Clotiazepam - 5-(2-clorofenil)-7-etil-1,3-di-hidro-1-metil-2H-tieno [2,3-e]-1,4-diazepina-2-ona", are both thienodiazepines, the same class as etizolam, printed Portuguese "tieno" marking the thiophene ring in both. So etizolam's ring system is not itself a reason Table IV could not reach it; the actual reason is narrower: etizolam is simply not named, and Table IV's own closing clause reaches only salts, "Os sais das substâncias indicadas nesta tabela, sempre que a existência de tais sais seja possível" (English: the salts of the substances listed in this table, whenever the existence of such salts is possible), with no isomer or analogue extension of the kind Table II-A carries. So even being chemically close to brotizolam or clotiazepam does not bring etizolam in. Etizolam was placed in Schedule IV of the 1971 Convention on Psychotropic Substances by a Commission on Narcotic Drugs decision in March 2020, after Lei 2/2017's 25 January 2017 enactment date (World Health Organization recommendation 13 December 2019, CND decision at its 63rd session), so its absence from the 2017 printed text is explained by timing alone; the open question is whether article 3, paragraph 3's self-executing update clause has since brought it in, which is not resolved by this reading. Only Decreto-Lei 2/2025 was checked as a candidate amending instrument and found not to amend Table IV; no broader search of the Jornal da República 2017 to 2026 for a separate amending law has been completed, and no instrument closing the question the way a No Subsidiary Legislation line would has been located either. On that scope, this is NOT VERIFIED rather than a confirmed absence. Article 3, paragraph 3, of Lei 2/2017 claims the tables update automatically with United Nations scheduling changes; whether that self-executes is not resolved by the printed text, and the printed list's own gaps confirm it: mephedrone (Table II-A item 26) and MDPV were both placed under Schedule II of the 1971 Convention by the same Commission on Narcotic Drugs 58th session, 9 to 17 March 2015, yet only mephedrone is named in the 2017 printed text (Table IV item 54 names only Pirovalerona, MDPV's older, chemically different parent compound); that confirmed gap shows the printed text cannot be trusted as fully current even at its own enactment.
Confirm directly with Timor-Leste’s national drug authority or your own embassy before you rely on anything.
What Timor-Leste HAS confirmed for related substances
This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
